MedQuist, SEC Settle; Execs Still On Hook For Fraud

Law360, New York (March 13, 2009, 12:00 AM EDT) -- The U.S. Securities and Exchange Commission on Thursday settled two suits with medical transcription company MedQuist Inc. and a former executive, and filed a third suit alleging that two former executives committed fraud and violated other federal securities laws by overcharging customers.

MedQuist has agreed to be permanently enjoined from violating the federal securities laws' antifraud, reporting, internal controls and books and records provisions, the SEC said in a statement Thursday. Medquist and its former Chief Operating Officer, John A. Donohoe, do not admit or deny...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.